Liver bioengineering: From the stage of liver decellularized matrix to the multiple cellular actors and bioreactor special effects
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Liver bioengineering has been a field of intense research and popular excitement in the past decades. It experiences great interest since the introduction of whole liver acellular scaffolds generated by perfusion decellularization (1-3). Nevertheless, the different strategies developed so far have failed to generate hepatic tissue in vitro bioequivalent to native liver tissue. Even notable novel strategies that rely on iPSC-derived liver progenitor cells potential to self-organize in association with endothelial cells in hepatic organoids are lacking critical components of the native tissue (e.g., bile ducts, functional vascular network, hepatic microarchitecture, etc) (4). Hence, it is vital to understand the strengths and short comes of our current strategies in this quest to re-create liver organogenesis in vitro. To shed some light into these issues, this review describes the different actors that play crucial roles in liver organogenesis and highlights the steps still missing to successfully generate whole livers and hepatic organoids in vitro for multiple applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
Uygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · cited 1×
“Primary hepatocytes are known to require between 7 to 10 d in culture before their metabolic activity and gene transcription levels stabilize.(78) During this period of time, mature hepatocytes seeded into the scaffold showed metabolic activity with urea and albumin production(2,3) and ammonia clearance,(2,63) drug me…”
BackgroundRegeneration and orthotopic transplantation of a bioartificial lung
Ott, H. C., Clippinger, B., Conrad, C., Schuetz, C., Pomerantseva, I., Ikonomou, L., Kotton, D., & Vacanti, J. P. (2010) · Nature Medicine · doi:10.1038/nm.2193 · Cited by 1,090
The final steps of integrin activation: the end game
Shattil, S. J., Kim, C., & Ginsberg, M. H. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2871 · Cited by 1,086 · cited 1×
“They also play a critical role during ontogeny, where morphogenetic cellular movement and migration enable the formation of new tissues and organs.(13) In this regard, hepatocytes and cholangiocytes have been shown to express markedly different combinations of integrins, which correlates with the differences in ECM co…”
BackgroundBadylak, S. F., Taylor, D., & Uygun, K. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124743 · Cited by 1,041 · cited 2×
“Nevertheless, its disadvantages are the increased risk of agent transmission and potential adverse immune reactions.(66) Stem/progenitor cells (hESC, iPSC, fetal liver cells, adultderived stem cells) can proliferate to large number of cells and differentiate to multiple cell lineages.”
BackgroundImmune response to biologic scaffold materials
Badylak, S. F., & Gilbert, T. W. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.003 · Cited by 857 · cited 1×
“All those residual antigens must be object of further studies to determine which defense mechanisms might be activated by the scaffold.(79,80) Currently, animal organs seem to be an extraordinary source of human size scaffolds, but their use also implies some potential issues.”
BackgroundOrganogenesis and development of the liver
Si-Tayeb, K., Lemaigre, F. P., & Duncan, S. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.01.011 · Cited by 800
Boulter, L., Govaere, O., Bird, T. G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R. A., Seo, S. S., Spee, B., Van Rooijen, N., et al. (2012) · Nature Medicine · doi:10.1038/nm.2667 · Cited by 747
Cited by
Yang, W., Chen, Q., Xia, R., Zhang, Y., Shuai, L., Lai, J., You, X., Jiang, Y., Bie, P., Zhang, L., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.026 · Cited by 30
Li, K., Tharwat, M., Larson, E. L., Felgendreff, P., Hosseiniasl, S. M., Rmilah, A. A., Safwat, K., Ross, J. J., & Nyberg, S. L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.833163 · Cited by 26
“For example, collagenous fibers from the vascular basement membrane that are exposed to blood flow activate the clotting cascade during extracorporeal blood perfusion or after in vivo transplantation (Kipshidze et al., 2004; Caralt et al., 2014; Wang et al., 2020).”
BackgroundStrategies for decellularization, re-cellularization and crosslinking in liver bioengineering
Wang, J., & Jin, X. (2024) · The International Journal of Artificial Organs · doi:10.1177/03913988231218566 · Cited by 3
Metadata
- Authors
- Caralt, M., Velasco, E., Lanas, A., & Baptista, P. M.
- Venue
- Organogenesis
- Publisher
- Informa UK Limited
- Published
- 2014-04
- Volume
- 10
- Issue
- 2
- Pages
- 250-259
- ISSN
- 1547-6278 (ISSN-L)
- 1555-8592
- OpenAlex
- W2025958855
- Cited by
- 42
- References
- 19
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.